Evidence map›Paper›PMID 42020426›Full record

ArticleNature communications2026

Human milk oligosaccharide mediates mutualism between Escherichia coli and Bifidobacterium bifidum.

David Seki, Shaul Pollak, Magdalena Kujawska, Raymond Kiu, Antia Acuna-Gonzalez, Lucy I Crouch, Cassie R Bakshani, Peter T Chivers, Monique Mommers, Nils van Best and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David SekiIntestinal Microbiome, School of Life Sciences, ZIEL - Institute for Food & Health, Technical University of Munich, Freising, Germany. david.seki@univie.ac.at.ORCID 0009-0005-9962-0422
Shaul PollakDepartment of Microbiology and Ecosystem Science, Division of Microbial Ecology, Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.ORCID 0000-0002-8976-5944
Magdalena KujawskaIntestinal Microbiome, School of Life Sciences, ZIEL - Institute for Food & Health, Technical University of Munich, Freising, Germany.ORCID 0000-0002-8842-3512
Raymond KiuDepartment of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0002-4483-1215
Antia Acuna-GonzalezFood, Microbiome and Health, Quadram Institute Bioscience, Norwich, UK.
Lucy I CrouchDepartment of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0003-1479-3534
Cassie R BakshaniDepartment of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Peter T ChiversDepartment of Biosciences, University of Durham, Durham, UK.ORCID 0000-0002-8779-1452
Monique MommersDepartment of Epidemiology, Caphri School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.
Nils van BestDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0003-3577-7285
John PendersDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0001-9146-5919
Lindsay J HallIntestinal Microbiome, School of Life Sciences, ZIEL - Institute for Food & Health, Technical University of Munich, Freising, Germany. l.hall.3@bham.ac.uk.ORCID 0000-0001-8938-5709

Funding

Wellcome Trust (Wellcome) 220876/Z/20/Z
6 · The paper itself

Abstract

Infant gut microbiota development involves frequent colonization by Enterobacteriaceae, particularly Escherichia coli, yet their ecological role in healthy infants is unclear. Here, we analyse longitudinal stool samples from healthy, term-born, breastfed infants (n = 41) and related mothers (n = 30) using shotgun metagenomics and novel computational approaches. Strain-resolved profiling indicates that Bifidobacterium species are frequently shared within families, whereas E. coli derive from external sources, but often persist within individuals. Despite differing ecological strategies, these genera co-exist and share evolutionary adaptations related to lactose acquisition in the infant gut. In vitro, we demonstrate that interactions between E. coli and Bifidobacterium bifidum are mutualistic in co-culture, where E. coli supplies cysteine to its auxotrophic partner, facilitating cooperative degradation of 2'-fucosyllactose, the predominant human milk oligosaccharide. In turn, the liberated monosaccharides sustain E. coli growth, highlighting a cooperative cross-feeding interaction that may contribute to regulating E. coli abundance within the infant host.

Indexed as

Bifidobacterium bifidumEscherichia coliMilk, HumanOligosaccharidesSymbiosisBreast FeedingFecesFemaleGastrointestinal MicrobiomeHumansInfantInfant, NewbornTrisaccharides2'-fucosyllactoseOligosaccharidesTrisaccharides

Identifiers

PMID42020426
PMCPMC13103366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.